Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ton Lisman

Showing results (181-190 of 362) with videos related to

Pageof 37
Sort By:
Haematologica|October 5, 2019
Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (<i>F2</i>) gene mutation in a Dutch Caucasian family with unexplained thrombosisRené Mulder, Ton Lisman, Joost C M Meijers, et al.
Blood|April 24, 2010
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in menMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|October 22, 2022
"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH": ReplyLara N Roberts, Ton Lisman, Simon Stanworth, et al.
Journal of Thrombosis and Haemostasis : JTH|February 6, 2025
Portal vein intimal thickening in patients with cirrhosis is associated with indicators of portal hypertensionEllen G Driever, Suzanne C Cannegieter, Stephen Gregory, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2022
Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTHLara N Roberts, Virginia Hernandez-Gea, Maria Magnusson, et al.
Research and Practice in Thrombosis and Haemostasis|October 2, 2025
Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver diseaseHinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, et al.
Plos Medicine|May 9, 2008
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisMirjam E Meltzer, Ton Lisman, Carine J M Doggen, et al.
Platelets|October 3, 2014
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinomaEdris M Alkozai, Robert J Porte, Jelle Adelmeijer, et al.
Thrombosis Research|December 2, 2014
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinomaEdris M Alkozai, Robert J Porte, Jelle Adelmeijer, et al.
Transplantation|June 9, 2023
Normothermic Machine-perfused Human Donor Livers Produce Functional Hemostatic ProteinsSilke B Bodewes, Bianca Lascaris, Jelle Adelmeijer, et al.
Pageof 37

Showing results (181-190 of 362) with videos related to

Sort By:
Pageof 37
Haematologica|October 5, 2019
Linkage analysis combined with whole-exome sequencing identifies a novel prothrombin (<i>F2</i>) gene mutation in a Dutch Caucasian family with unexplained thrombosisRené Mulder, Ton Lisman, Joost C M Meijers, et al.
Blood|April 24, 2010
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in menMirjam E Meltzer, Carine J M Doggen, Philip G de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|October 22, 2022
"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH": ReplyLara N Roberts, Ton Lisman, Simon Stanworth, et al.
Journal of Thrombosis and Haemostasis : JTH|February 6, 2025
Portal vein intimal thickening in patients with cirrhosis is associated with indicators of portal hypertensionEllen G Driever, Suzanne C Cannegieter, Stephen Gregory, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2022
Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTHLara N Roberts, Virginia Hernandez-Gea, Maria Magnusson, et al.
Research and Practice in Thrombosis and Haemostasis|October 2, 2025
Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver diseaseHinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, et al.
Plos Medicine|May 9, 2008
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisMirjam E Meltzer, Ton Lisman, Carine J M Doggen, et al.
Platelets|October 3, 2014
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinomaEdris M Alkozai, Robert J Porte, Jelle Adelmeijer, et al.
Thrombosis Research|December 2, 2014
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinomaEdris M Alkozai, Robert J Porte, Jelle Adelmeijer, et al.
Transplantation|June 9, 2023
Normothermic Machine-perfused Human Donor Livers Produce Functional Hemostatic ProteinsSilke B Bodewes, Bianca Lascaris, Jelle Adelmeijer, et al.
Pageof 37